Report overview
A Controlled Substance Ordering System (CSOS) is a form of digital identity issued by the Drug Enforcement Administration?s CSOS Certification Authority, allowing electronic ordering of controlled substances under Schedule I, II, III, and IV. The CSOS certificate is the digital equivalent of identity information in the DEA Form-222. The Life Sciences Controlled Substance Ordering System Market mainly caters to individual buyers and it is a mandatory requirement for ordering Schedule I and Schedule II drugs. The CSOS certificate enables the power of attorneys and DEA registrants to order controlled substances electronically by providing identification and authentication details through digital signatures. While the paper DEA form-222 is still technically allowed, the CSOS certificate is the only way Schedule I and II drugs can be ordered today.
This report contains market size and forecasts of Life Sciences Controlled Substance Ordering System in Global, including the following market information:
Global Life Sciences Controlled Substance Ordering System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Life Sciences Controlled Substance Ordering System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Centralised Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Life Sciences Controlled Substance Ordering System include Axway, Vormetric, Legisym, The Drummond Group, Attain Med and Bound Tree Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Life Sciences Controlled Substance Ordering System companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Life Sciences Controlled Substance Ordering System Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Life Sciences Controlled Substance Ordering System Market Segment Percentages, by Type, 2021 (%)
Centralised Systems
Cloud-Based Systems
Others
Global Life Sciences Controlled Substance Ordering System Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Life Sciences Controlled Substance Ordering System Market Segment Percentages, by Application, 2021 (%)
Service Providers
Individual Buyers
Global Life Sciences Controlled Substance Ordering System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Life Sciences Controlled Substance Ordering System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Life Sciences Controlled Substance Ordering System revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Life Sciences Controlled Substance Ordering System revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Axway
Vormetric
Legisym
The Drummond Group
Attain Med
Bound Tree Medical
